Robert W. Rieder

Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada.

Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.

Magnum Uranium Corp. (MM:TSX.V) is a Canadian-based exploration company focused on the acquisition and development of a high-quality portfolio of uranium properties. Magnum's corporate strategy is to acquire advanced-stage uranium properties that are either past producers, have been the subject of prior work programs and/or contain historic resources. Additionally, Magnum will acquire selective early-stage properties should they possess significant geologic merit. Magnum has a proven track record of acquiring projects that meet these criteria as evidenced by its present portfolio. Company's geographic focus is the Western United States, where it have acquired uranium properties in Idaho, Utah, Wyoming, New Mexico, and Canada's Athabasca Basin. The company was founded in 1984 and is headquartered in Vancouver, Canada.

Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada.

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.

Bradmer Pharmaceuticals, Inc. engaged in the development and commercialization of cancer therapies. The company was founded on June 16, 2005 and wass headquartered in Toronto, Canada.

DBA Telecommunication (Asia) Holdings Ltd. is an investment holding company, which provides intelligent payment services. The company operates through the following segments: Information Technology, Intelligent Self-service and Agency. The Information Technology segment designs, manufactures and sells telecommunication equipment and related products. The Intelligent Self-service segment engages in payment service in public utility including pre-paid phone cards, water, electricity and gas through sales of pre-paid cards and recharging services. It also provides electronic payment and settlement services. The Agency segment engages in trading of telecommunication products. The company was founded on June 15, 2004 and is headquartered in Hong Kong.